Results isoprenaline (30nM) experiment. حسب L. Cao (3526226)

Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods. حسب Amrita Banerjee (382658)

Developmental delay of <i>rpS13/+</i> animals is not due to a decrease in ribosome numbers or reduced translation rates. حسب Lisa Patricia Deliu (13570709)

Mean squared error of estimates decreases with larger datasets. حسب Alexander Eugene Zarebski (12078347)

"…<p>The mean squared error in the estimates of under the posterior distribution decreases as the size of the dataset increases. …"

Decrease of the mean number of natural teeth and POPs with age. حسب Sul-Hee Kim (11873853)

Fig 5 - حسب Zhi Zhang (55283)

Global Land Use Change Impacts on Soil Nitrogen Availability and Environmental Losses حسب Jing Wang (6206297)

"…By compiling a global data set of 1,782 paired observations from 185 publications, we show that land use conversion from natural to managed ecosystems significantly reduced NNM by 7.5% (−11.5, −2.8%) and increased NN by 150% (86, 194%), indicating decreasing N availability while increasing potential N loss through denitrification and nitrate leaching. …"

Detailed meta–analyses in untreated hypothyroid patients compared with controls for each HRV parameters: RR intervals, SDNN, RMSSD, pNN50, TP, LF, HF, LF/HF. حسب Valentin Brusseau (12769704)

Combined decitabine and Taxol decreases MCF-7/Taxol cells proliferation and can improve their chemosensitivity. حسب Weihua Gong (471435)

Competition localization increases with growth rate or the distances between colonies, and decreases with the resource diffusion constant. حسب Jeremy M. Chacón (8259792)

Retinoic acid decreases intracellular K⁺ in pectoral fin buds via transcriptional activation of the calcineurin inhibitor <i>rcan2</i>. حسب Xiaowen Jiang (8291814)

Clinical outcome (3-month mean drop in HbA1c) by incentive group. حسب Leonard E. Egede (8097272)

Mean decrease in accuracy (MDA) of top 15 urine metabolites. حسب Liam E. Broughton-Neiswanger (8447220)

"…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…"

Experimental features ranked with respect to their mean decrease in the Gini index. حسب Rajib Mukherjee (532424)

The Mean Decreasing Gini OTU importance plot for the fecal samples. حسب Zaid Abdo (175649)

Flow chart of the study procedures. حسب Kazuhiko Ikeuchi (9234268)

"…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…"

Random forest analysis showing discriminating biomarkers of diet-challenge in their decreasing orders of mean decrease accuracies (MDA). حسب Biswapriya B. Misra (563793)

TMEM182 decreases OSCC cell motility. حسب En-Wei Hsing (154990)

Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... حسب Shuai Wang (109515)

"…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC₅₀ = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …"

Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance... حسب Shuai Wang (109515)

"…Targeting P-glycoprotein (ABCB1 or P-gp) has been recognized as a promising strategy to overcome multidrug resistance. Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo­[1,5-<i>a</i>]­pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC₅₀ = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …"